Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: A population-based prospective study

British Journal of Cancer

Volumn 105, Issue 7, 2011, Pages 1061-1068

  Discacciati, A ^a   Orsini, N ^a   Andersson, S O ^b   Andren O ^b   Johansson, J E ^b   Wolk, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

body mass index; body size; obesity; prospective cohort study; prostate cancer

Indexed keywords

ADULT; ADULTHOOD; ADVANCED CANCER; AGED; ARTICLE; BODY MASS; CANCER RISK; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; BODY MASS INDEX; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL RATE; SWEDEN;

EID: 80053256686     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.319     Document Type: Article

References (59)

1. Akaike H (1974) New look at statistical model identification. IEEE Trans Automat Contr AC 19(6): 716-723
2. Bell GI, Polonsky KS (2001) Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414(6865): 788-791 (Pubitemid 34000781)
3. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ (2010) Body-mass index and mortality among 1.46 million white adults. N Engl J Med 363(23): 2211-2219
4. Burton A, Martin R, Galobardes B, Davey Smith G, Jeffreys M (2010) Young adulthood body mass index and risk of cancer in later adulthood: historical cohort study. Cancer Causes Control 21(12): 2069-2077
5. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348(17): 1625-1638 (Pubitemid 36459468)
6. Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB, Lubaroff DM, Wallace RB (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8(2): 229-238 (Pubitemid 27170378)
7. D0Amico AV, Chen MH, Malkowicz SB, Whittington R, Renshaw AA, Tomaszewski JE, Samofalov Y, Wein A, Richie JP (2002) Lower prostate specific antigen outcome than expected following radical prostatectomy in patients with high grade prostate and a prostatic specific antigen level of 4 ng/ml. Or less. J Urol 167(5): 2025-2030; discussion 2030-2031 (Pubitemid 34309651)
8. Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribu-tion of a competing risk. J Am Stat Assoc 94(446): 496-509
9. Fodstad P, Bjoro T, Torlakovic G, Fossa SD (2002) No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 pN0M0 prostate cancer. J Urol 168(3): 1188-1192
10. Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29: 88-97 (Pubitemid 47229642)
11. Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev 11(10 Part 1): 1041-1047 (Pubitemid 35192655)
12. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 121(7): 1571-1578 (Pubitemid 47328718)
13. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6(8): 557-563 (Pubitemid 27342677)
14. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1998) Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9(1): 3-9 (Pubitemid 28048654)
15. Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15(10): 1977-1983 (Pubitemid 44664277)
16. Gronberg H (2003) Prostate cancer epidemiology. Lancet 361(9360): 859-864 (Pubitemid 36331852)
17. Hoffman MA, DeWolf WC, Morgentaler A (2000) Is low serum free testosterone a marker for high grade prostate cancer? J Urol 163(3): 824-827 (Pubitemid 30091624)
18. Hsing AW (1996) Hormones and prostate cancer: where do we go from here? J Natl Cancer Inst 88(16): 1093-1095
19. Hsing AW, Sakoda LC, Chua Jr S (2007) Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 86(3): s843-s857
20. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2): 69-90
21. Jonsson H, Holmstrom B, Duffy SW, Stattin P (2011) Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. Int J Cancer; doi:10.1002/ijc.25846 (in press)
22. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78(3): 744-752 (Pubitemid 24083322)
23. Kaaks R, Lukanova A (2001) Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60(1): 91-106 (Pubitemid 32183103)
24. Kaaks R, Lukanova A, Sommersberg B (2000) Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review. Prostate Cancer Prostatic Dis 3(3): 157-172
25. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER (1993) Androgen-stimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth-hormone and insulin-like growth factor-I in the treatment of short stature and delayed puberty. J Clin Endocr Metab 76(4): 996-1001 (Pubitemid 23110851)
26. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S (2006) Association of body mass index and height with risk of prostate cancer among middle-aged Japanese men. Br J Cancer 94(5): 740-742 (Pubitemid 43361908)
27. Kuskowska-Wolk A, Karlsson P, Stolt M, Rossner S (1989) The predictive validity of body mass index based on self-reported weight and height. Int J Obes 13(4): 441-453
28. Lima N, Cavaliere H, Knobel M, Halpern A, Medeiros-Neto G (2000) Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. Int J Obes Relat Metab Disord 24(11): 1433-1437
29. Littman AJ, White E, Kristal AR (2007) Anthropometrics and prostate cancer risk. Am J Epidemiol 165(11): 1271-1279 (Pubitemid 47234324)
30. Lukanova A, Soderberg S, Stattin P, Palmqvist R, Lundin E, Biessy C, Rinaldi S, Riboli E, Hallmans G, Kaaks R (2002) Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden). Cancer Causes Control 13(6): 509-516 (Pubitemid 34833103)
31. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG (2003) Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 12(12): 1417-1421 (Pubitemid 38031743)
32. Massengill JC, Sun L, Moul JW, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Donahue T (2003) Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 169(5): 1670-1675 (Pubitemid 36443468)
33. Mattsson B, Wallgren A (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23(5): 305-313
34. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB (1997) Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone. Int J Obes Relat Metab Disord 21(5): 355-359 (Pubitemid 27190186)
35. NBHW (2000) Cancer Incidence in Sweden 1998: The National Board of Health and Welfare, Centre of Epidemiology: Stockholm. Report no. 91-7201-450-4
36. Norman A, Bellocco R, Bergstrom A, Wolk A (2001) Validity and reproducibility of self-reported total physical activity-differences by relative weight. Int J Obes Relat Metab Disord 25(5): 682-688 (Pubitemid 32417638)
37. Norman A, Bellocco R, Vaida F, Wolk A (2002) Total physical activity in relation to age, body mass, health and other factors in a cohort of Swedish men. Int J Obes Relat Metab Disord 26(5): 670-675 (Pubitemid 34499288)
38. Okasha M, McCarron P, McEwen J, Smith GD (2002) Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Community Health 56(10): 780-784
39. Orsini N, Bellocco R, Bottai M, Pagano M, Andersson SO, Johansson JE, Giovannucci E, Wolk A (2009) A prospective study of lifetime physical activity and prostate cancer incidence and mortality. Br J Cancer 101(11): 1932-1938
40. Pasquali R, Casimirri F, Cantobelli S, Melchionda N, Morselli Labate AM, Fabbri R, Capelli M, Bortoluzzi L (1991) Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism 40(1): 101-104
41. Pischon T, Boeing H, Weikert S, Allen N, Key T, Johnsen NF, Tjonneland A, Severinsen MT, Overvad K, Rohrmann S, Kaaks R, Trichopoulou A, Zoi G, Trichopoulos D, Pala V, Palli D, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, May A, Manjer J, Wallstrom P, Stattin P, Hallmans G, Buckland G, Larranaga N, Chirlaque MD, Martinez C, Redondo Cornejo ML, Ardanaz E, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Riboli E (2008) Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 17(11): 3252-3261
42. Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E (2005) Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 14(5): 1262-1269 (Pubitemid 40656478)
43. Price MM, Hamilton RJ, Robertson CN, Butts MC, Freedland SJ (2008) Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Urology 71(5): 787-791
44. Putnam SD, Cerhan JR, Parker AS, Bianchi GD, Wallace RB, Cantor KP, Lynch CF (2000) Lifestyle and anthropometric risk factors for prostate cancer in a cohort of Iowa men. Ann Epidemiol 10(6): 361-369 (Pubitemid 30645790)
45. Revicki DA, Israel RG (1986) Relationship between body mass indices and measures of body adiposity. Am J Public Health 76(8): 992-994 (Pubitemid 16074105)
46. Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB, Metter EJ, Chen C, Weiss NS, Fitzpatrick A, Hsing AW, Lacey Jr JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schroder FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry Jr CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Johansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7): 461-471, W83-8
47. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16(1): 63-69 (Pubitemid 46174265)
48. Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ (2001) Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev 10(4): 345-353 (Pubitemid 32703219)
49. Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28(5): 964-974 (Pubitemid 29525041)
50. Schatzl G, Madersbacher S, Thurridl T, Waldmuller J, Kramer G, Haitel A, Marberger M (2001) High-grade prostate cancer is associated with low serum testosterone levels. Prostate 47(1): 52-58 (Pubitemid 32246752)
51. Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151(6): 541-549 (Pubitemid 30463598)
52. Severi G, Morris HA, MacInnis RJ, English DR, Tilley W, Hopper JL, Boyle P, Giles GG (2006) Circulating steroid hormones and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15(1): 86-91
53. Stocks T, Hergens MP, Englund A, Ye W, Stattin P (2010) Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort. Int J Cancer 127(7): 1660-1668
54. The NS, Suchindran C, North KE, Popkin BM, Gordon-Larsen P (2010) Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 304(18): 2042-2047
55. Wallstrom P, Bjartell A, Gullberg B, Olsson H, Wirfalt E (2009) A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk. Br J Cancer 100(11): 1799-1805
56. Wang Y (2002) Is obesity associated with early sexual maturation? A comparison of the association in American boys versus girls. Pediatrics 110(5): 903-910 (Pubitemid 35266148)
57. Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T, Hurwitz P, Hollenbeck A, Leitzmann MF (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4): 675-684 (Pubitemid 46233228)
58. Yamamoto H, Kato Y (1993) Relationship between plasma insulin-like growth factor I (IGF-I) levels and body mass index (BMI) in adults. Endocr J 40(1): 41-45 (Pubitemid 23265494)
59. Zumoff B (1988) Hormonal abnormalities in obesity. Acta Med Scand Suppl 723: 153-160